Longstanding Phenytoin Use as a Cause of Progressive Dyspnea

Longstanding Phenytoin Use as a Cause of Progressive Dyspnea

Case Presentation: A 54-year-old South African man with a medical history of type 2 diabetes mellitus, seizure disorder, OSA, and latent TB presented to the ER with gradually progressive dyspnea over months. He also reported occasional dry cough and fatigue at presentation but denied fever, chills,...

Full description

Bibliographic Details
Main Authors: Al Omari, O. (Author), Jani, C. (Author), McCannon, J. (Author), Patel, D. (Author), Perrino, C. (Author), Rupal, A. (Author), Singh, H. (Author), Walker, A. (Author)
Format: Article
Language:English
Published: Elsevier Inc. 2022
Subjects:
biopsy
Biopsy
case report
complication
COVID-19
Diagnosis, Differential
diagnostic imaging
differential diagnosis
drug substitution
Drug Substitution
dyspnea
Dyspnea
epidemiology
human
Humans
interstitial lung disease
lacosamide
Lacosamide
lung
Lung
Lung Diseases, Interstitial
male
Male
middle aged
Middle Aged
pathology
pathophysiology
phenytoin
Phenytoin
procedures
SARS-CoV-2
seizure
Seizures
Tomography, X-Ray Computed
treatment outcome
Treatment Outcome
voltage gated sodium channel blocking agent
Voltage-Gated Sodium Channel Blockers
x-ray computed tomography
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items